BioSpace News Archive

Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration has accepted the company’s supplemental Biologics License Application and granted Priority Review for the use of Rituxan®, in combination with glucocorticoids, for the treatment of granulomatosis with polyangiitis and microscopic polyangiitis in children two years of age and older.

Sensorion announces a convertible bond issue with a nominal value of 20 million euros subscribed by two new investors, Invus Public Equities LP as the anchor investor and Sofinnova Crossover I SLP as co-anchor investor.

Just as women can turn to a suite of procedures, known as the “Mommy Makeover,” more men are embracing their own set of treatments, the “Daddy-Do-Over,” to boost their confidence and improve their physical appearance.

Dr. Eric Hoskins, Chair of the Advisory Council on the Implementation of National Pharmacare, accompanied by Mr. Vincent Dumez, Member of the Advisory Council on the Implementation of National Pharmacare, will present the final report and its recommendations to the Government of Canada.

BioInvent International AB announces the publication of the first data from two parallel Phase l/lla clinical trials of its lead product candidate BI-1206 as single agent and/or in combination with rituximab, currently being conducting in the UK and the US/EU respectively.

The acquisition means that the previously announced exclusive licence agreement with Novimmune will be superseded.

Leading window and door brand puts sound performance on dynamic display with home activation showcasing noise-reducing window and patio door products Monday, June 17, 2019 from 4 p.m. to 7 p.m.

HISP P&S accreditation recognizes excellence in health data processing and transactions, and ensures compliance with HIPAA Privacy and Security provisions

The Muscular Dystrophy Association and Locana, a leading RNA-targeting gene therapy company, announced the award of an MDA Venture Philanthropy grant totaling $550,000 to advance Locana’s development program for myotonic dystrophy.

Members of the NantHealth Connected Care Team to Highlight the Importance of Interoperability in Today’s Global Health Care Ecosystem